• 1
    Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R. Two domains of anosognosia in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1996; 61: 485490.
  • 2
    Starkstein SE, Jorge R, Mizrahi R, Robinson RG. A diagnostic formulation for anosognosia in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2006; 77: 719725.
  • 3
    Migliorelli R, Teson A, Sabe L et al. Anosognosia in Alzheimer's disease: A study of associated factors. J. Neuropsychiatry Clin. Neurosci. 1995; 7: 338344.
  • 4
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939944.
  • 5
    Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br. J. Psychiatry 1982; 140: 566572.
  • 6
    Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975; 12: 189198.
  • 7
    Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 23082314.
  • 8
    Hirono N, Mori E, Ikejiri Y et al. Japanese version of the neuropsychiatric inventory: A scoring system for neuropsychiatric disturbance in dementia patients. No To Shinkei 1997; 49: 266271.
  • 9
    Hirono N, Yamadori A, Mori E, Yamashita H, Tokimasa A. Daily living activities of patients with Alzheimer's disease. Jpn. J. Neuropsychol. 1995; 11: 186195.
  • 10
    Nunnally JC. Psychometrics Theory, 2nd edn. McGraw-Hill, New York, 1978.
  • 11
    Reed BR, Jagust WJ, Coulter L. Anosognosia in Alzheimer's disease: Relationships to depression, cognitive function, and cerebral perfusion. J. Clin. Exp. Neuropsychol. 1993; 15: 231244.
  • 12
    Matsui T, Nakaaki S, Murata Y et al. Determinants of the quality of life in Alzheimer's disease patients as assessed by the Japanese version of the Quality of Life-Alzheimer's disease scale. Dement. Geriatr. Cogn. Disord. 2006; 21: 182191.
  • 13
    Korth B. The distribution of chance congruence coefficients from simulated date. Psychometrika 1975; 40: 361371.
  • 14
    Tekin S, Fairbanks LA, O'Connor S, Rosenberg S, Cummings JL. Activities of daily living in Alzheimer's disease: Neuropsychiatric, cognitive, and medical illness influences. Am. J. Geriatr. Psychiatry 2001; 9: 8186.
  • 15
    Boyle PA, Malloy PF, Salloway S et al. Executive dysfunction and apathy predict functional impairment in Alzheimer disease. Am. J. Geriatr. Psychiatry 2003; 11: 214221.
  • 16
    Stout JC, Wyman MF, Johnson SA, Peavy GM, Salmon DP. Frontal behavioral syndromes and functional status in probable Alzheimer disease. Am. J. Geriatr. Psychiatry 2003; 11: 683686.
  • 17
    Levy ML, Cummings JL, Fairbanks LA et al. Apathy is not depression. J. Neuropsychiatry Clin. Neurosci. 1998; 10: 314319.
  • 18
    Snow AL, Graham DP, Molinari VA et al. Factors affecting deficit awareness in persons with dementia. Dement. Geriatr. Cogn. Disord. 2005; 20: 133139.
  • 19
    Michon A, Deweer B, Agid Y, Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1994; 57: 805809.